Real-World data sought on prostate cancer combo therapy

NCT ID NCT06380738

First seen Jun 27, 2026 · Last updated Jul 17, 2026 · Updated 1 time

Summary

This study watches how men with a certain advanced prostate cancer (mCRPC) do when taking the drugs olaparib and abiraterone in everyday medical practice. It will track about 250 patients for up to 2 years to see how long they stay on treatment and what happens next. The goal is to learn more about real-world results, not to test a new treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC CASTRATION-RESISTANT PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Research Site

    RECRUITING

    Aschaffenburg, Germany

  • Research Site

    RECRUITING

    Augsburg, Germany

  • Research Site

    RECRUITING

    Bergisch Gladbach, Germany

  • Research Site

    RECRUITING

    Berlin, Germany

  • Research Site

    RECRUITING

    Bonn, Germany

  • Research Site

    RECRUITING

    Cologne, Germany

  • Research Site

    RECRUITING

    Dresden, Germany

  • Research Site

    RECRUITING

    Duisburg, Germany

  • Research Site

    RECRUITING

    Eisenach, Germany

  • Research Site

    RECRUITING

    Eisleben Lutherstadt, Germany

  • Research Site

    RECRUITING

    Frankfurt, Germany

  • Research Site

    RECRUITING

    Greifswald, Germany

  • Research Site

    RECRUITING

    Halle, Germany

  • Research Site

    RECRUITING

    Hamburg, Germany

  • Research Site

    RECRUITING

    Hanover, Germany

  • Research Site

    RECRUITING

    Heidelberg, Germany

  • Research Site

    RECRUITING

    Heinsberg, Germany

  • Research Site

    RECRUITING

    Herzogenaurach, Germany

  • Research Site

    RECRUITING

    Leipzig, Germany

  • Research Site

    RECRUITING

    Lübeck, Germany

  • Research Site

    RECRUITING

    Lüneburg, Germany

  • Research Site

    RECRUITING

    Magdeburg, Germany

  • Research Site

    RECRUITING

    Marburg, Germany

  • Research Site

    RECRUITING

    Mülheim, Germany

  • Research Site

    RECRUITING

    Münster, Germany

  • Research Site

    RECRUITING

    Neunkirchen, Germany

  • Research Site

    RECRUITING

    Nuremberg, Germany

  • Research Site

    RECRUITING

    Rüsselsheim am Main, Germany

  • Research Site

    RECRUITING

    Saalfeld, Germany

  • Research Site

    RECRUITING

    Speyer, Germany

  • Research Site

    RECRUITING

    Trier, Germany

  • Research Site

    RECRUITING

    Tübingen, Germany

  • Research Site

    RECRUITING

    Westerstede, Germany

  • Research Site

    RECRUITING

    Wetzlar, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.